# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-174414
Filing Date
2023-06-26
Accepted
2023-06-26 07:00:37
Documents
42
Period of Report
2023-06-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d483814d6k.htm | 6-K | 8315
2 | EX-99.1 | d483814dex991.htm | EX-99.1 | 59612
3 | GRAPHIC | g483814ex99_1p10g1.jpg | GRAPHIC | 414413
4 | GRAPHIC | g483814ex99_1p11g1.jpg | GRAPHIC | 250753
5 | GRAPHIC | g483814ex99_1p12g1.jpg | GRAPHIC | 55025
6 | GRAPHIC | g483814ex99_1p13g1.jpg | GRAPHIC | 266239
7 | GRAPHIC | g483814ex99_1p14g1.jpg | GRAPHIC | 225363
8 | GRAPHIC | g483814ex99_1p15g1.jpg | GRAPHIC | 242063
9 | GRAPHIC | g483814ex99_1p16g1.jpg | GRAPHIC | 286231
10 | GRAPHIC | g483814ex99_1p17g1.jpg | GRAPHIC | 288777
11 | GRAPHIC | g483814ex99_1p18g1.jpg | GRAPHIC | 233207
12 | GRAPHIC | g483814ex99_1p19g1.jpg | GRAPHIC | 307839
13 | GRAPHIC | g483814ex99_1p20g1.jpg | GRAPHIC | 62935
14 | GRAPHIC | g483814ex99_1p21g1.jpg | GRAPHIC | 271436
15 | GRAPHIC | g483814ex99_1p22g1.jpg | GRAPHIC | 212992
16 | GRAPHIC | g483814ex99_1p23g1.jpg | GRAPHIC | 219640
17 | GRAPHIC | g483814ex99_1p24g1.jpg | GRAPHIC | 248685
18 | GRAPHIC | g483814ex99_1p25g1.jpg | GRAPHIC | 261565
19 | GRAPHIC | g483814ex99_1p26g1.jpg | GRAPHIC | 265309
20 | GRAPHIC | g483814ex99_1p27g1.jpg | GRAPHIC | 279211
21 | GRAPHIC | g483814ex99_1p28g1.jpg | GRAPHIC | 309208
22 | GRAPHIC | g483814ex99_1p29g1.jpg | GRAPHIC | 57965
23 | GRAPHIC | g483814ex99_1p30g1.jpg | GRAPHIC | 196462
24 | GRAPHIC | g483814ex99_1p31g1.jpg | GRAPHIC | 250917
25 | GRAPHIC | g483814ex99_1p32g1.jpg | GRAPHIC | 276322
26 | GRAPHIC | g483814ex99_1p33g1.jpg | GRAPHIC | 223467
27 | GRAPHIC | g483814ex99_1p34g1.jpg | GRAPHIC | 237195
28 | GRAPHIC | g483814ex99_1p35g1.jpg | GRAPHIC | 62097
29 | GRAPHIC | g483814ex99_1p36g1.jpg | GRAPHIC | 254564
30 | GRAPHIC | g483814ex99_1p37g1.jpg | GRAPHIC | 58272
31 | GRAPHIC | g483814ex99_1p38g1.jpg | GRAPHIC | 198414
32 | GRAPHIC | g483814ex99_1p39g1.jpg | GRAPHIC | 319553
33 | GRAPHIC | g483814ex99_1p40g1.jpg | GRAPHIC | 208719
34 | GRAPHIC | g483814ex99_1p41g1.jpg | GRAPHIC | 182630
35 | GRAPHIC | g483814ex99_1p42g1.jpg | GRAPHIC | 239049
36 | GRAPHIC | g483814ex99_1p43g1.jpg | GRAPHIC | 80436
37 | GRAPHIC | g483814ex99_1p5g1.jpg | GRAPHIC | 156883
38 | GRAPHIC | g483814ex99_1p6g1.jpg | GRAPHIC | 469769
39 | GRAPHIC | g483814ex99_1p7g1.jpg | GRAPHIC | 314022
40 | GRAPHIC | g483814ex99_1p8g1.jpg | GRAPHIC | 340860
41 | GRAPHIC | g483814ex99_1p9g1.jpg | GRAPHIC | 302346
42 | GRAPHIC | g483814g0501123228320.jpg | GRAPHIC | 8035
| Complete submission text file | 0001193125-23-174414.txt |  | 12659932

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 231039406
SIC: 2834 Pharmaceutical Preparations